https://www.moneycontrol.com/news/business/stocks/zydus-lifesciences-rises-2-on-launch-of-cancer-drug-olaparib-12452921.html
0
0
3/14/24 at 3:58am
Organization
Moneycontrol
Author
Moneycontrol News
The drug will target specific genetic mutations prevalent in certain types of cancers, paving the way for more tailored and effective treatment approach.
Create an account
or login to join the discussion